Kalled Musallam: A Comprehensive Review of Thalassemia
Kalled Musallam, Group Chief Research Officer at Burjeel Holdings and Deputy CEO and Chief of Cellular and Gene Therapy and Hematology at Burjeel Cancer Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nature Reviews Disease Primers, adding:
“Pleased to share our new comprehensive review on thalassemia published today in Nature Reviews Disease Primers, one of the leading journals from the Nature portfolio (impact factor 80), which will hopefully provide thalassemia with greater visibility across the broader scientific and medical community.”
Title: Thalassaemia
Authors: Frédéric B. Piel, Mariane de Montalembert, Reena Das, Kevin H. M. Kuo, Ali T. Taher, Khaled M. Musallam, Marsha Treadwell, Suthat Fucharoen, Michael Angastiniotis, Douglas Higgs, Elliott Vichinsky, Maria Domenica Cappellini, Lucia De Franceschi
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 15:02Sham Zamil: The Role of ABO Compatibility in Platelet Pooling
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:56Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:34Jim Hoffman: Separating Evidence from Misinformation on Vaccine-Associated Thrombosis